Literature DB >> 30247975

Bioresponsive polyplexes - chemically programmed for nucleic acid delivery.

Simone Hager1, Ernst Wagner1.   

Abstract

INTRODUCTION: The whole delivery process of nucleic acids is very challenging. Appropriate carrier systems are needed, which show extracellular stability and intracellular disassembly. Viruses have developed various strategies to meet these requirements, as they are optimized by biological evolution to transfer genetic information into host cells. Taking viruses as models, smart synthetic carriers can be designed, mimicking the efficient delivery process of viral infection. These 'synthetic viruses' are pre-programmed and respond to little differences in their microenvironment, caused by either exogenous or endogenous stimuli. AREAS COVERED: This review deals with polymer-based, bioresponsive nanosystems (polyplexes) for the delivery of nucleic acids. Strategies utilizing pH-responsiveness, redox-responsiveness as well as sensitivity towards enzymes will be described more in detail. Systems, which respond to other endogenous triggers (i.e. reactive oxygen species, adenosine triphosphate, hypoxia), will be briefly illustrated. Moreover, some examples for combined bioresponsiveness will be presented. EXPERT OPINION: Bioresponsive polyplexes are a smart way to facilitate programmed, timely delivery of nucleic acids to desired, specific sites. Nevertheless, further optimization is necessary to improve the still moderate transfection efficiency and specificity - also in regard to medical translation. For this purpose, precise carrier structures are desirable and stability issues of bioresponsive systems must be considered.

Entities:  

Keywords:  Adenosine triphosphate (ATP); bioreducible; bioresponsive; endogenous trigger; hypoxia; non-viral nucleic acid delivery systems; pH; polyplexes; reactive oxygen species (ROS); redox potential

Mesh:

Substances:

Year:  2018        PMID: 30247975     DOI: 10.1080/17425247.2018.1526922

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  4 in total

Review 1.  The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.

Authors:  Carolin Kitzberger; Rebekka Spellerberg; Volker Morath; Nathalie Schwenk; Kathrin A Schmohl; Christina Schug; Sarah Urnauer; Mariella Tutter; Matthias Eiber; Franz Schilling; Wolfgang A Weber; Sibylle Ziegler; Peter Bartenstein; Ernst Wagner; Peter J Nelson; Christine Spitzweg
Journal:  EJNMMI Res       Date:  2022-05-03       Impact factor: 3.434

Review 2.  Spatiotemporal control of CRISPR/Cas9 gene editing.

Authors:  Chenya Zhuo; Jiabin Zhang; Jung-Hwan Lee; Ju Jiao; Du Cheng; Li Liu; Hae-Won Kim; Yu Tao; Mingqiang Li
Journal:  Signal Transduct Target Ther       Date:  2021-06-20

3.  Effective lung-targeted RNAi in mice with peptide-based delivery of nucleic acid.

Authors:  Kaido Kurrikoff; Krista Freimann; Kadi-Liis Veiman; Elin Madli Peets; Andres Piirsoo; Ülo Langel
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

Review 4.  Nucleic Acid-Based Approaches for Tumor Therapy.

Authors:  Simone Hager; Frederic Julien Fittler; Ernst Wagner; Matthias Bros
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.